Innoviva (INVA) EBITDA Margin Growth (3y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -40,178.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 530.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -932.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 7,003.00 |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn | 146,431.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 146,431.00 |
| Dec 31, 2025 | -29,133.00 |
| Sep 30, 2025 | 3,169.00 |
| Jun 30, 2025 | 53,826.00 |
| Mar 31, 2025 | 75,669.00 |
| Dec 31, 2024 | -24,183.00 |
| Sep 30, 2024 | -4,831.00 |
| Jun 30, 2024 | -821,067.00 |
| Mar 31, 2024 | -54,895.00 |
| Dec 31, 2023 | 84,986.00 |
| Sep 30, 2023 | 3,260.00 |
| Jun 30, 2023 | -107,855.00 |
| Mar 31, 2023 | -152,212.00 |
| Dec 31, 2022 | -107,961.00 |
| Sep 30, 2022 | -9,207.00 |
| Jun 30, 2022 | -58,286.00 |
| Mar 31, 2022 | -80,449.00 |
| Dec 31, 2021 | -70,822.00 |
| Sep 30, 2021 | 313.00 |
| Jun 30, 2021 | 817,199.00 |
| Mar 31, 2021 | -58,754.00 |
| Dec 31, 2020 | -137,588.00 |
| Sep 30, 2020 | 1,292.00 |
| Jun 30, 2020 | 1,433.00 |
| Mar 31, 2020 | 2,428.00 |
| Dec 31, 2019 | 1,058.00 |
| Sep 30, 2019 | 864.00 |
| Jun 30, 2019 | 1,353.00 |
| Mar 31, 2019 | 2,202.00 |
| Dec 31, 2018 | 2,097.00 |
| Sep 30, 2018 | 3,130.00 |
| Jun 30, 2018 | 4,548.00 |
| Mar 31, 2018 | 6,689.00 |
| Dec 31, 2017 | 9,374.00 |
| Sep 30, 2017 | 103,743.00 |
| Jun 30, 2017 | 113,028.00 |
| Mar 31, 2017 | 196,003.00 |
| Dec 31, 2016 | 58,988.00 |
| Sep 30, 2016 | 194,092.00 |
| Jun 30, 2016 | 60,148.00 |
| Mar 31, 2016 | 259,801.00 |
| Dec 31, 2015 | 4,185.00 |
| Sep 30, 2015 | 239,436.00 |
| Jun 30, 2015 | 687,566.00 |
| Mar 31, 2015 | -5,759.00 |
| Dec 31, 2014 | 66,525.00 |
| Sep 30, 2014 | -50,107.00 |
| Jun 30, 2014 | -67,833.00 |
| Mar 31, 2014 | -155,109.00 |